T. Frieden, T. Sterling, S. Munsiff, C. Watt, and C. Dye, Tuberculosis, The Lancet, vol.362, issue.9387, pp.887-899, 2003.
DOI : 10.1016/S0140-6736(03)14333-4

R. Van-crevel, T. Ottenhoff, and J. Van-der-meer, Innate Immunity to Mycobacterium tuberculosis, Clinical Microbiology Reviews, vol.15, issue.2, pp.294-309, 2002.
DOI : 10.1128/CMR.15.2.294-309.2002

T. Means, S. Wang, L. E. Yoshimura, A. Golenbock, and D. , Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis, J Immunol, vol.163, pp.3920-3927, 1999.

A. Aliprantis, R. Yang, M. Mark, S. Sugget, and B. Devaux, Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2, Science, vol.285, issue.5428, pp.736-739, 1999.
DOI : 10.1126/science.285.5428.736

C. Vignal, Y. Guerardel, L. Kremer, M. Masson, and D. Legrand, Lipomannans, But Not Lipoarabinomannans, Purified from Mycobacterium chelonae and Mycobacterium kansasii Induce TNF-?? and IL-8 Secretion by a CD14-Toll-Like Receptor 2-Dependent Mechanism, The Journal of Immunology, vol.171, issue.4, pp.2014-2023, 2003.
DOI : 10.4049/jimmunol.171.4.2014
URL : https://hal.archives-ouvertes.fr/hal-00149429

M. Gilleron, V. Quesniaux, and G. Puzo, Acylation State of the Phosphatidylinositol Hexamannosides from Mycobacterium bovis Bacillus Calmette Guerin and Mycobacterium tuberculosis H37Rv and Its Implication in Toll-like Receptor Response, Journal of Biological Chemistry, vol.278, issue.32, pp.29880-29889, 2003.
DOI : 10.1074/jbc.M303446200
URL : https://hal.archives-ouvertes.fr/hal-00177668

J. Nigou, C. Zelle-rieser, M. Gilleron, M. Thurnher, and G. Puzo, Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor, The Journal of Immunology, vol.166, issue.12, pp.7477-7485, 2001.
DOI : 10.4049/jimmunol.166.12.7477
URL : https://hal.archives-ouvertes.fr/hal-00177977

T. Geijtenbeek, V. Vliet, S. Koppel, E. Sanchez-hernandez, M. Vanderbroucke-grauls et al., Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function, The Journal of Experimental Medicine, vol.93, issue.1, pp.7-17, 2003.
DOI : 10.1084/jem.192.9.1213

N. Reiling, C. Holscher, A. Fehrenbach, K. Svenja, and C. Kirschning, Cutting Edge: Toll-Like Receptor (TLR)2- and TLR4-Mediated Pathogen Recognition in Resistance to Airborne Infection with Mycobacterium tuberculosis, The Journal of Immunology, vol.169, issue.7, pp.3480-3484, 2002.
DOI : 10.4049/jimmunol.169.7.3480

A. Kamath, J. Alt, H. Debbabi, and S. Behar, Toll-Like Receptor 4-Defective C3H/HeJ Mice Are Not More Susceptible than Other C3H Substrains to Infection with Mycobacterium tuberculosis, Infection and Immunity, vol.71, issue.7, pp.4112-4118, 2003.
DOI : 10.1128/IAI.71.7.4112-4118.2003

B. Abel, N. Thieblemont, V. Quesniaux, N. Brown, and J. Mpagi, Toll-Like Receptor 4 Expression Is Required to Control Chronic Mycobacterium tuberculosis Infection in Mice, The Journal of Immunology, vol.169, issue.6, pp.3155-3162, 2002.
DOI : 10.4049/jimmunol.169.6.3155
URL : https://hal.archives-ouvertes.fr/hal-00095132

J. Branger, J. Leemans, S. Florquin, S. Weijer, and P. Speelman, Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice, International Immunology, vol.16, issue.3, pp.509-516, 2004.
DOI : 10.1093/intimm/dxh052

M. Drennan, D. Nicolle, V. Quesniaux, M. Jacobs, and A. N. , Toll-Like Receptor 2-Deficient Mice Succumb to Mycobacterium tuberculosis Infection, The American Journal of Pathology, vol.164, issue.1, pp.49-57, 2004.
DOI : 10.1016/S0002-9440(10)63095-7

I. Sugawara, H. Yamada, C. Li, S. Mizuno, and O. Takeuchi, Mycobacterial Infection in TLR2 and TLR6 Knockout Mice, Microbiology and Immunology, vol.69, issue.5, pp.327-336, 2003.
DOI : 10.1111/j.1348-0421.2003.tb03404.x

C. Fremond, V. Yeremeev, D. Nicolle, M. Jacobs, and V. Quesniaux, Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88, Journal of Clinical Investigation, vol.114, issue.12, pp.1790-1799, 2004.
DOI : 10.1172/JCI200421027
URL : https://hal.archives-ouvertes.fr/hal-00094932

J. Hugot, M. Chamaillard, H. Zouali, S. Lesage, and J. Cezard, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, vol.411, issue.6837, pp.599-603, 2001.
DOI : 10.1038/35079107

Y. Ogura, D. Bonen, N. Inohara, L. Nicolae, and F. Chen, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, vol.411, issue.6837, pp.603-606, 2001.
DOI : 10.1038/35079114

S. Girardin, I. Boneca, J. Viala, M. Chamaillard, and A. Labigne, Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection, Journal of Biological Chemistry, vol.278, issue.11, pp.8869-8872, 2003.
DOI : 10.1074/jbc.C200651200

S. Girardin, I. Boneca, L. Carneiro, A. Antignac, and M. Jehanno, Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan, Science, vol.300, issue.5625, pp.1584-1587, 2003.
DOI : 10.1126/science.1084677

V. Quesniaux, C. Fremond, M. Jacobs, S. Parida, and D. Nicolle, Toll-like receptor pathways in the immune responses to mycobacteria, Microbes and Infection, vol.6, issue.10, pp.946-959, 2004.
DOI : 10.1016/j.micinf.2004.04.016

M. Netea, B. Kullberg, D. De-jong, B. Francke, and T. Sprong, NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease, European Journal of Immunology, vol.34, issue.7, pp.2052-2059, 2004.
DOI : 10.1002/eji.200425229

J. Ting and B. Davis, CATERPILLER: A Novel Gene Family Important in Immunity, Cell Death, and Diseases, Annual Review of Immunology, vol.23, issue.1, pp.387-414, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115616

M. Netea, G. Ferwerda, D. Jong, D. Werts, C. Boneca et al., The Frameshift Mutation in Nod2 Results in Unresponsiveness Not Only to Nod2- but Also Nod1-activating Peptidoglycan Agonists, Journal of Biological Chemistry, vol.280, issue.43, 2005.
DOI : 10.1074/jbc.M504924200

M. Netea, G. Ferwerda, D. Jong, D. Jansen, T. Jacobs et al., Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release, The Journal of Immunology, vol.174, issue.10, pp.6518-6523, 2005.
DOI : 10.4049/jimmunol.174.10.6518

B. Opitz, A. Puschel, B. Schmeck, A. Hocke, and S. Rosseau, Nucleotide-binding Oligomerization Domain Proteins Are Innate Immune Receptors for Internalized Streptococcus pneumoniae, Journal of Biological Chemistry, vol.279, issue.35, pp.36426-36432, 2004.
DOI : 10.1074/jbc.M403861200

R. Greenstein, Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease, The Lancet Infectious Diseases, vol.3, issue.8, pp.507-514, 2003.
DOI : 10.1016/S1473-3099(03)00724-2

S. Naser, G. Ghobrial, C. Romero, and J. Valentine, Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease, The Lancet, vol.364, issue.9439, pp.1039-1044, 2004.
DOI : 10.1016/S0140-6736(04)17058-X

S. Endres, R. Ghorbani, G. Lonnemann, J. Van-der-meer, and C. Dinarello, Measurement of immunoreactive interleukin-1?? from human mononuclear cells: Optimization of recovery, intrasubject consistency, and comparison with interleukin-1?? and tumor necrosis factor, Clinical Immunology and Immunopathology, vol.49, issue.3, pp.424-438, 1988.
DOI : 10.1016/0090-1229(88)90130-4

O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, and H. Takada, Differential Roles of TLR2 and TLR4 in Recognition of Gram-Negative and Gram-Positive Bacterial Cell Wall Components, Immunity, vol.11, issue.4, pp.443-451, 1999.
DOI : 10.1016/S1074-7613(00)80119-3

B. Kullberg, J. Van-'t-wout, and C. Hoogstraten, Recombinant Interferon-?? Enhances Resistance to Acute Disseminated Candida albicans Infection in Mice, Journal of Infectious Diseases, vol.168, issue.2, pp.436-443
DOI : 10.1093/infdis/168.2.436

J. Drenth, V. Uum, S. Van-deuren, M. Pesman, G. Van-der-ven-jongekrijg et al., Endurance run increases circulating IL-6 and IL- 1ra but downregulates ex vivo TNF-a and IL-1b production, J Appl Physiol, vol.79, pp.1497-1503, 1995.

M. Netea, P. Demacker, B. Kullberg, O. Boerman, and I. Verschueren, Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections., Journal of Clinical Investigation, vol.97, issue.6, pp.1366-1372, 1996.
DOI : 10.1172/JCI118556

E. Lien, T. Means, H. Heine, A. Yoshimura, and S. Kusumoto, Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide, Journal of Clinical Investigation, vol.105, issue.4, pp.497-504, 2000.
DOI : 10.1172/JCI8541